Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review
Psychological Medicine 2025 Chiara Caporuscio, Christopher Poppe, Astrid Gieselmann et al. 9 citations
Abstract Based on promising preliminary results from clinical trials, it seems likely that psychedelic substances (classic serotonergic psychedelics, such as psilocybin, and entactogens, such as MDMA) will be introduced into psychiatry as psychedelic-assisted therapy. This also raises a range of ethical questions that urgently need to be addressed before widespread roll-out in society. This...